-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
20
2025-01
New year, new momentum; fresh spring, new initiatives. Kexuan Pharmaceutical will take this performance review meeting as an opportunity to align our vision even more closely around achieving our 2025 targets. We’ll intensify our focus on market expansion, procurement optimization, lean production, organizational development, and safety & environmental protection—all while staying profit-driven, leveraging R&D as our engine of growth and ensuring robust system support. Let’s transform our work style, strengthen our execution and learning capabilities, act decisively without delay or evasion, respond swiftly, and remain relentlessly committed until we reach our goals—no excuses, no compromises!
2025-01-20
17
2025-01
During the exchange, both sides engaged in an in-depth discussion on key technologies and industrialization in synthetic biology, as well as the preparation and promotion of raw materials for cosmetics and medical aesthetics. Experts highly praised Keyuan Pharmaceutical's innovative capabilities and technical expertise in the pharmaceutical manufacturing sector, and expressed their strong willingness to collaborate with the company on industry-academia-research partnerships.
2025-01-17
15
2025-01
This training session was organized by the Information Center, and all members of the company's management team and heads of first-level departments attended. Drawing on their extensive hands-on experience and solid theoretical knowledge, the information experts provided attendees with a clear and insightful explanation of ERP systems—covering essential concepts, functional modules, operational procedures, and real-world case studies. The content spanned various areas, including supply chain management, production planning, financial management, and human resource management, equipping the management team with a comprehensive understanding of ERP systems' powerful capabilities and vast potential for practical application.
2025-01-15
14
2025-01
The successful convening of this year's 2025 Annual Target Promotion and Implementation Meeting marks a solid step forward for Keyuan Pharmaceutical in planning and executing its strategic goals for 2025. By clarifying the direction, establishing clear guidelines, defining specific measures, and strengthening execution, the company has laid a robust foundation for smoothly advancing subsequent tasks—and ensuring that it achieves a strong start to both the first month and the first quarter!
2025-01-14
05
2025-01
The meeting began with a comprehensive review of the company’s safety production efforts for 2024. Over the past year, Keyuan Pharmaceutical has consistently adhered to the guiding principle of "Safety First, Prevention-Oriented, and Comprehensive Management." By strengthening safety management, refining safety protocols, and intensifying safety training, the company has effectively elevated its overall safety standards, successfully achieving its annual goals: "zero safety incidents, zero environmental pollution, and zero administrative penalties" for the entire year.
2025-01-05
31
2024-12
2024: Gleaming Footprints—The Annual Mark of Innovation and Breakthrough
2024 Shining Footprints: The Yearly Imprint of Innovation and Breakthroughs
2024-12-31
30
2024-12
At the vibrant peak of youth at twenty, it’s the perfect time to continue writing our inspiring chapter! In 2024, Keyuan Pharmaceutical celebrates its 20th anniversary. To mark this historic milestone, the company recently hosted a special symposium, inviting senior employees who have dedicated 20 years to the organization, as well as employee representatives from various generations who joined the company over the years. Together, they reflected on Keyuan’s remarkable two-decade journey and looked forward to shaping an even brighter future ahead.
2024-12-30
26
2024-12
The event kicked off with the rousing "Lino Anthem," as management presented the five core product teams—each representing isosorbide mononitrate, gliclazide, sacubitril valsartan sodium, mecobalamin, and lurasidone hydrochloride—with flags symbolizing both honor and responsibility. Each flag embodies the company's profound aspirations for future growth, and all employees are determined to work together seamlessly, jointly driving marketing efforts to new heights in the coming year.
2024-12-26
24
2024-12
For years, Keyuan Pharmaceutical has actively participated in various public welfare activities and donated a wide range of charitable materials, demonstrating its corporate social responsibility through concrete actions. This not only earned the company widespread recognition from society and enhanced its positive public image but also strengthened employee cohesion and sense of belonging, laying a solid social foundation for the company’s high-quality, sustainable growth.
2024-12-24
13
2024-12
Since the launch of the competition, all employees of Keyuan Pharmaceutical have enthusiastically responded, picking up their cameras or smartphones to capture the focus and passion at work, as well as the warmth and beauty in everyday life—from various perspectives.
2024-12-13
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline